Alcanza Clinical Research acquires Innovation Medical Research Center

Alcanza Clinical Research has acquired Innovation Medical Research Center. This deal is a key part of Alcanza’s growth strategy, marking the ninth acquisition since 2021, and enabling the site network to expand its therapeutic area capabilities and diversity of study participants.

Located in Palmetto Bay, Fla., Innovation conducts Phase I to Phase IV clinical trials in key therapeutic areas such as cardiology, dermatology, endocrinology, gastroenterology, infectious disease, internal medicine, nephrology, neurology, psychiatry, rheumatology, and women’s health.

“As Alcanza continues to expand, the addition of Innovation strengthens our capabilities in a variety of high-growth therapeutic areas,” said Carlos Orantes, CEO, Alcanza. “Additionally, the center’s prime location enables us to reach new, diverse patient populations, aligning with our mission to make clinical research accessible to everyone.”

“Joining an established site network, such as Alcanza, whose mission and values are closely aligned with ours, is vital to the continued growth and success of Innovation,” said Omar Orama, Site Director.
MB Bureau